1α,25-Dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells

Molecular and Cellular Endocrinology

Volumn 263, Issue 1-2, 2007, Pages 55-64

  Lechner, Daniel ^a   Kállay, Enikö ^a   Cross, Heide S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast; Colon; CYP24A1 (25 D3 24 hydroxylase); CYP27B1 (25 D3 1 hydroxylase); Prostate; Tumor therapy

Indexed keywords

CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; MESSENGER RNA; VITAMIN D RECEPTOR; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; CHOLESTANETRIOL 26 MONOOXYGENASE; RNA;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; COLON; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; ENZYMOLOGY; HUMAN; HUMAN CELL; HYDROXYLATION; IN VITRO STUDY; MALE; MAMMARY GLAND; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; VITAMIN D METABOLISM; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; COLON TUMOR; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; BLOTTING, WESTERN; BREAST NEOPLASMS; CALCITRIOL; CELL DIFFERENTIATION; COLONIC NEOPLASMS; CYTOCHROME P-450 CYP27A1; DOWN-REGULATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 33847113262     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.08.009     Document Type: Article

References (50)

1. Albertson D.G., Ylstra B., Segraves R., Collins C., Dairkee S.H., Kowbel D., Kuo W.L., Gray J.W., and Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25 (2000) 144-146
2. Anderson P.H., O'Loughlin P.D., May B.K., and Morris H.A. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone 36 (2005) 654-662
3. Armbrecht H.J., Boltz M.A., Hodam T.L., and Kumar V.B. Differential responsiveness of intestinal epithelial cells to 1,25-dihydroxyvitamin D3-role of protein kinase C. J. Endocrinol. 169 (2001) 145-151
4. Astecker N., Reddy G.S., Herzig G., Vorisek G., and Schuster I. 1alpha,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes. Mol. Cell. Endocrinol. 170 (2000) 91-101
5. Bani D., Riva A., Bigazzi M., and Bani Sacchi T. Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin. Br. J. Cancer 70 (1994) 900-904
6. Barbour G.L., Coburn J.W., Slatopolsky E., Norman A.W., and Horst R.L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N. Engl. J. Med. 305 (1981) 440-443
7. Bareis P., Bises G., Bischof M.G., Cross H.S., and Peterlik M. 25-Hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem. Biophys. Res. Commun. 285 (2001) 1012-1017
8. Barletta F., Dhawan P., and Christakos S. Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E598-E608
9. Bischof M.G., Siu-Caldera M.L., Weiskopf A., Vouros P., Cross H.S., Peterlik M., and Reddy G.S. Differentiation-related pathways of 1 alpha,25-dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: production of 1 alpha,25-dihydroxy-3epi-cholecalciferol. Exp. Cell. Res. 241 (1998) 194-201
10. Bises G., Kallay E., Weiland T., Wrba F., Wenzl E., Bonner E., Kriwanek S., Obrist P., and Cross H.S. 25-Hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon. J. Histochem. Cytochem. 52 (2004) 985-989
11. Bland R., Walker E.A., Hughes S.V., Stewart P.M., and Hewison M. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 140 (1999) 2027-2034
12. Chen K.S., and DeLuca H.F. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3, 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim. Biophys. Acta 1263 (1995) 1-9
13. Chen T.C., Wang L., Whitlatch L.W., Flanagan J.N., and Holick M.F. Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J. Cell Biochem. 88 (2003) 315-322
14. Cross H.S., Bareis P., Hofer H., Bischof M.G., Bajna E., Kriwanek S., Bonner E., and Peterlik M. 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66 (2001) 287-292
15. Cross H.S., Bises G., Lechner D., Manhardt T., and Kallay E. The Vitamin D endocrine system of the gut-its possible role in colorectal cancer prevention. J. Steroid Biochem. Mol. Biol. 97 (2005) 121-128
16. Cross H.S., Kallay E., Lechner D., Gerdenitsch W., Adlercreutz H., and Armbrecht H.J. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J. Nutr. 134 (2004) 1207S-1212S
17. Cross H.S., Pavelka M., Slavik J., and Peterlik M. Growth control of human colon cancer cells by vitamin D and calcium in vitro. J. Natl. Cancer Inst. 84 (1992) 1355-1357
18. Cross H.S., Peterlik M., Reddy G.S., and Schuster I. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J. Steroid Biochem. Mol. Biol. 62 (1997) 21-28
19. Degeorges A., Hoffschir F., Cussenot O., Gauville C., Le Duc A., Dutrillaux B., and Calvo F. Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line. Int. J. Cancer 62 (1995) 724-731
20. Dilworth F.J., Scott I., Green A., Strugnell S., Guo Y.D., Roberts E.A., Kremer R., Calverley M.J., Makin H.L., and Jones G. Different mechanisms of hydroxylation site selection by liver and kidney cytochrome P450 species (CYP27 and CYP24) involved in vitamin D metabolism. J. Biol. Chem. 270 (1995) 16766-16774
21. Fogh J., Wright W.C., and Loveless J.D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58 (1977) 209-214
22. Friedlander E.J., Henry H.L., and Norman A.W. Studies on the mode of action of calciferol. Effects of dietary calcium and phosphorus on the relationship between the 25-hydroxyvitamin D3-1alpha-hydroxylase and production of chick intestinal calcium binding protein. J. Biol. Chem. 252 (1977) 8677-8683
23. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., and Portale A.A. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 11 (1997) 1961-1970
24. Garland C.F., and Garland F.C. Do sunlight and vitamin D reduce the likelihood of colon cancer?. Int. J. Epidemiol. 9 (1980) 227-231
25. Grant W.B. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94 (2002) 1867-1875
26. Henry H.L. Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells. J. Biol. Chem. 254 (1979) 2722-2729
27. Hsu J.Y., Feldman D., McNeal J.E., and Peehl D.M. Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res. 61 (2001) 2852-2856
28. Jones G., Ramshaw H., Zhang A., Cook R., Byford V., White J., and Petkovich M. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 140 (1999) 3303-3310
29. Kamao M., Tatematsu S., Hatakeyama S., Sakaki T., Sawada N., Inouye K., Ozono K., Kubodera N., Reddy G.S., and Okano T. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation. J. Biol. Chem. 279 (2004) 15897-15907
30. Kawashima H., Torikai S., and Kurokawa K. Calcitonin selectively stimulates 25-hydroxyvitamin D3-1 alpha-hydroxylase in proximal straight tubule of rat kidney. Nature 291 (1981) 327-329
31. Khorchide M., Lechner D., and Cross H.S. Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells. J. Steroid Biochem. Mol. Biol. 93 (2005) 167-172
32. Lechner D., Bajna E., Adlercreutz H., and Cross H.S. Genistein and 17beta-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res. 26 (2006) 2597-2603
33. Ly L.H., Zhao X.Y., Holloway L., and Feldman D. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140 (1999) 2071-2076
34. Makin G., Lohnes D., Byford V., Ray R., and Jones G. Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem. J. 262 (1989) 173-180
35. Masuda S., Byford V., Arabian A., Sakai Y., Demay M.B., St-Arnaud R., and Jones G. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 146 (2005) 825-834
36. Mickey D.D., Stone K.R., Wunderli H., Mickey G.H., and Paulson D.F. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. Prog. Clin. Biol. Res. 37 (1980) 67-84
37. Murayama A., Takeyama K., Kitanaka S., Kodera Y., Hosoya T., and Kato S. The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. Biochem. Biophys. Res. Commun. 249 (1998) 11-16
38. Rost C.R., Bikle D.D., and Kaplan R.A. In vitro stimulation of 25-hydroxycholecalciferol 1 alpha-hydroxylation by parathyroid hormone in chick kidney slices: evidence for a role for adenosine 3′,5′-monophosphate. Endocrinology 108 (1981) 1002-1006
39. Sheinin Y., Kaserer K., Wrba F., Wenzl E., Kriwanek S., Peterlik M., and Cross H.S. In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch. 437 (2000) 501-507
40. Skowronski R.J., Peehl D.M., and Feldman D. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132 (1993) 1952-1960
41. Soule H.D., Vazguez J., Long A., Albert S., and Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51 (1973) 1409-1416
42. St-Arnaud R., Arabian A., Travers R., Barletta F., Raval-Pandya M., Chapin K., Depovere J., Mathieu C., Christakos S., Demay M.B., and Glorieux F.H. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141 (2000) 2658-2666
43. Takeyama K., Kitanaka S., Sato T., Kobori M., Yanagisawa J., and Kato S. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277 (1997) 1827-1830
44. Townsend K., Banwell C.M., Guy M., Colston K.W., Mansi J.L., Stewart P.M., Campbell M.J., and Hewison M. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin. Cancer Res. 11 (2005) 3579-3586
45. Townsend K., Evans K.N., Campbell M.J., Colston K.W., Adams J.S., and Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J. Steroid Biochem. Mol. Biol. 97 (2005) 103-109
46. Vaisanen S., Dunlop T.W., Sinkkonen L., Frank C., and Carlberg C. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-dihydroxyvitamin D3. J. Mol. Biol. 350 (2005) 65-77
47. Weaver V.M., Franks D.J., and Welsh J.E. Activation of protein kinase C modulates dihydroxycholecalciferol synthesis in rat renal tubules. Cell. Signal. 4 (1992) 293-301
48. Weinstein E.A., Rao D.S., Siu-Caldera M.L., Tserng K.Y., Uskokovic M.R., Ishizuka S., and Reddy G.S. Isolation and identification of 1alpha-hydroxy-24-oxovitamin D3 and 1alpha,23-dihydroxy-24-oxovitamin D3: metabolites of 1alpha,24(R)-dihydroxyvitamin D3 produced in rat kidney. Biochem. Pharmacol. 58 (1999) 1965-1973
49. Xie Z., Munson S.J., Huang N., Portale A.A., Miller W.L., and Bikle D.D. The mechanism of 1,25-dihydroxyvitamin D(3) autoregulation in keratinocytes. J. Biol. Chem. 277 (2002) 36987-36990
50. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., and Hewison M. Extra-renal expression of 25-hydroxyvitamin D3-1α-hydroxylase. J. Clin. Endocrinol. Metab. 86 (2001) 888-894